Wednesday, July 8, 2026

pharma · Infertility · Ovarian Cancer · NWBO

NORTHWEST BIOTHERAPEUTICS

NORTHWEST BIOTHERAPEUTICS is a pharma organization headquartered in Bethesda, USA. It trades on NYSE under ticker NWBO. Primary therapeutic focus areas include Infertility, Ovarian Cancer, Environmental Exposure, Colorec

4800 Montgomery Lane, Suite 800, Bethesda, MD 28014, US HQ
1998 Founded
20 Employees
Public company Type
NWBO · NYSE Ticker
Company details
Status
Public
HQ
4800 Montgomery Lane, Suite 800, Bethesda, MD 28014, US
Founded
1998
Employees
20
Programs
33
Drugs
40
Patents
595
Clinical program

DCVax-Direct

Phase 2 · mab · Locally Advanced Tumor

DCVax-Direct for Locally Advanced Tumor is a Phase 2 program (mab) at NORTHWEST BIOTHERAPEUTICS INC with 1 ClinicalTrials.gov record(s).

Internal code NWBio 050012

Full intelligence profile for this program is being prepared.

At a glance

Sponsor
NORTHWEST BIOTHERAPEUTICS INC
Phase
Phase 2
Modality
mab
Indication
Locally Advanced Tumor
Status
active
Trials
1

Clinical trials